The construct Hp1018/19Δsp was amplified from genomic DNA of H. pylori strain 26695 using the primers 5′-aaggatccggcaatatccaaatccagagcatg-3′ and 5′-aagaattcgacccacccctatcatttcacc-3′ with Pfx DNA polymerase in supplied buffer with 2× PCR Enhancer (Invitrogen). The amplified BamH1/EcoR1 flanked PCR product was then ligated into the pGEM-T Easy plasmid (Promega), subcloned into the pGEX-6P-1 plasmid DNA (GE Healthcare Life Sciences) and transformed in E. coli BL21. The construction of the protease-inactive Hp1018/19ΔspS205A protein, serine 205 was mutated to alanine using the QuikChange® Lightning Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions. For heterologous overexpression and purification of GST-Hp1018/19Δsp, transformed E. coli was grown in 500 ml TB medium to an OD550 of 0.6 and the expression was induced by the addition of 0.1 mM isopropylthiogalactosid (IPTG). The bacterial culture was pelleted at 4000×g for 30 minutes and lysed in 25 ml PBS by sonification. The lysate was cleared by centrifugation and the supernatant was incubated with glutathione sepharose (GE Healthcare Life Sciences) at 4°C over night. The fusion protein was either eluted with 10 mM reduced glutathione for 10 minutes at room temperature or cleaved with 180 U Prescission Protease for 16 h at 4°C (GE Healthcare Life Sciences). Elution and cleavage products were analyzed by SDS PAGE and zymography.
Free full text: Click here